Page last updated: 2024-11-05

thenoyltrifluoroacetone and Kidney Neoplasms

thenoyltrifluoroacetone has been researched along with Kidney Neoplasms in 1 studies

Thenoyltrifluoroacetone: Chelating agent and inhibitor of cellular respiration.

Kidney Neoplasms: Tumors or cancers of the KIDNEY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tong, WH1
Sourbier, C1
Kovtunovych, G1
Jeong, SY1
Vira, M1
Ghosh, M1
Romero, VV1
Sougrat, R1
Vaulont, S1
Viollet, B1
Kim, YS1
Lee, S1
Trepel, J1
Srinivasan, R1
Bratslavsky, G1
Yang, Y1
Linehan, WM1
Rouault, TA1

Other Studies

1 other study available for thenoyltrifluoroacetone and Kidney Neoplasms

ArticleYear
The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels.
    Cancer cell, 2011, Sep-13, Volume: 20, Issue:3

    Topics: Acetyl Coenzyme A; Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Basic Helix-Loop-

2011
chemdatabank.com